A Phase I, Single Centre, Open-Label Study to Assess the Pharmacokinetics of Both AZD9056 (Steady State) and Simvastatin (Single Dose) When Co-Administered in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 01 Dec 2010
At a glance
- Drugs AZD 9056 (Primary) ; Simvastatin
- Indications Hyperlipidaemia; Osteoarthritis; Rheumatoid arthritis
- Focus Pharmacokinetics
- 01 Dec 2010 Additional trial location (Germany) identified as reported by ClinicalTrials.gov.
- 01 Dec 2010 Actual end date changed from Nov 2008 to Sep 2008 as reported by ClinicalTrials.gov.
- 08 Jan 2009 Actual end date changed from Sep 2008 to Nov 2008 as reported by Clinicaltrials.gov.